Search

Your search keyword '"Boucher, D"' showing total 1,166 results
Start Over Author "Boucher, D"

Refine your results

more »

more »

more »

more »

more »
1,166 results on '"Boucher, D"'

4. Factors influencing fire suppression success in the province of Quebec (Canada)

Author

Cardil, A., Lorente, M., Boucher, D., Boucher, J., and Gauthier, S.

Subjects
Prescribed burning -- Case studies -- Analysis -- Protection and preservation, Forest fires -- Case studies -- Analysis -- Protection and preservation -- Control -- Quebec, Firefighting equipment, Earth sciences
Abstract

In the managed forest of Canada, forest fires are actively suppressed through efficient initial attack capability; however, the impact of different factors on the suppression success remains to be understood. The aim of this paper was to analyze the influence of operational suppression objectives (fire detection, initial attack, and fire control) along with fire intensity, fuel type, fire ignition cause, year, workload, and homogeneous fire regime zones on the achievement of the fire suppression objective (fire < 3 ha) using the Forest Fire Protection Agency of Quebec (SOPFEU) as a case study. The overall success of the suppression objective was very high (88%) over the study period (1994-2015). Both detection and control had significant effects on the suppression success through their interaction with fuel type, ignition cause, fire intensity, and zone variables. When the suppression objective was not achieved, final fire size was influenced by control, fuel type, fire intensity, and zone. The paper highlights the importance of the operational objectives and of regional differences for both fire suppression success and final fire size. Our results can help forest fire protection agencies to better understand their wildland fire suppression systems for a better adaptation to the upcoming fire regime changes. Key words: Forest Fire Protection Agency, fire management, Quebec (Canada), suppression objectives, wildland fire. Dans les forets amenagees du Canada, les feux de foret sont reprimes rapidement grace a une capacite d'attaque initiale tres efficace; cependant, les facteurs qui influencent la reussite de la suppression necessitent une meilleure comprehension. L'objectif de cette etude etait d'analyser l'influence des objectifs operationnels de la suppression (la detection, l'attaque initiale et le controle de l'incendie) ainsi que de l'intensite du feu, du type de combustible, de la cause de l'incendie, de l'annee, de la charge de travail et des zones homogenes de feux dans l'atteinte de l'objectif de suppression des feux (feux < 3 ha) en utilisant la Societe de protection des forets contre le feu du Quebec (SOPFEU) comme etude de cas. Le taux d'atteinte de l'objectif final de suppression etait tres eleve (88 %) au cours de la periode d'etude (1994-2015). La detection et le controle avaient un effet significatif sur le succes de la suppression en interaction avec le type de combustible, la cause de l'allumage, l'intensite du feu et les caracteristiques des zones. Lorsque l'objectif de suppression n'etait pas atteint, la taille finale du feu etait influencee par le succes du controle, le type de combustible, l'intensite du feu et la zone. L'article souleve l'importance des objectifs operationnels et des differences regionales dans le succes de la suppression des feux et dans la taille finale du feu. Nos resultats peuvent aider les societes de protection des forets contre les incendies a mieux comprendre leur systeme de gestion des feux de foret et favoriser l'adaptation aux changements a venir dans les regimes des feux. Mots-cles: Societe de protection des forets contre le feu, gestion des incendies, Quebec (Canada), objectifs de suppression, feu de foret., Introduction Most countries subject to important forest fires invest substantial resources to protect people, forest-dependent communities, timber, and other resources from wildland fires (Martell 2001; Cardil and Molina 2013). For [...]

Published
2019
Full Text
View/download PDF

5. Sovereignty in a global village

Author

Boucher, D. S.

Subjects
327
Abstract

This thesis subjects the relevance of sovereignty in the context of globalization to critical examination, mindful of the increasing contentions today that sovereignty should either be abandoned or relegated to practical insignificance. Defined as a spatio-temporal revolution whose implications are corrosive of the assumptions upon which modern territorial sovereignty lay, the thesis recognises that sovereignty certainly faces significant challenges. Having subjected this spatio-temporal revolution and its implications for sovereignty to detailed analysis, however, it pursues what might be described as a middle way identifying the ongoing importance of sovereignty but also the urgent need for a measure of reconceptualisation. In the first instance the thesis observes that, whilst the reality of a growing extra-territorial realm is beyond question, it coexists with territoriality and thus territorial sovereignty rather than displacing it. Indeed the thesis argues that the extra-territorial realm depends on sovereign territoriality in many different ways, especially in terms of legitimacy. In the second instance, however, whilst state sovereignty is not displaced by the spatio-temporal revolution its influence is most certainly eroded. Furthermore, the reality of extra-territorial flows means that there can be no doubt that, whilst sovereignty remains a significant concept, it will be the source of much distortion if it fails to recognise those flows. This thesis responds to these observations pursuing the reconceptualisation of sovereignty in search of a new form of 'open sovereignty'. In rising to this challenge it provides a critique both of those seeking to jettison sovereignty or relegate it to insignificance and those who maintain that globalization has no impact on sovereignty. In pursuing this course the thesis exploits the spatio-temporal hermeneutic of traditional Welsh nationalism which, recognizing the new temporality of globalization in the context of an enduring spatial orientation, provides a significant conceptual frame for IR in the 21st century.

Published
2000

10. Report of the iMOST Study

Author

Zorzano, M.P, Zipfel, J, Wheeler, R.M, Westall, F, Werner, S.C, Weiss, B.P, Wadhwa, M, Van Kranendonk, M.J, Usui, T, Tosca, N.J, Kate, I.L, Swindle, T.D, Steele, A, Spry, J.A, Smith, C.L, Siljeström, S, Shuster, D.L, Sharp, Z.D, Shaheen, R, Sephton, M.A, Schwenzer, S.P, Schmitz, N, Rucker, M.A, Rettberg, P, Raulin, F, Ori, G.G, Niles, P.B, Mustard, J.F, Moynier, F, Moser, D.E, McLennan, S.M, McCubbin, F.M, McCoy, J.T, Mayhew, L.E, Mangold, N, Mackelprang, R, Kleinhenz, J, Kleine, T, Humayun, M, Horgan, B, Herd, C.D.K, Hausrath, E.M, Harrington, A.D, Hallis, L.J, Goreva, Y.S, Glavin, D.P, Fogarty, J, Filiberto, J, Fernandez-Remolar, D.C, Farmer, J.D, Ehlmann, B.L, Dixon, M, Des Marais, D.J, Debaille, V, Czaja, A.D, Campbell, K.A, Busemann, H, Brucato, J.R, Boucher, D, Borg, L.E, Bishop, J.L, Benning, L.G, Anand, M, Ammannito, E, Amelin, Y, Altieri, F, Carrier, B. L, Sefton-Nash, E, McSween, H. Y, Grady, M. M, and Beaty, D. W

Abstract

UNKNOWN

Published
2018

11. Report of the iMOST Study

Author

Beaty, D. W, Grady, M. M, McSween, H. Y, Sefton-Nash, E, Carrier, B. L, Altieri, F, Amelin, Y, Ammannito, E, Anand, M, Benning, L.G, Bishop, J.L, Borg, L.E, Boucher, D, Brucato, J.R, Busemann, H, Campbell, K.A, Czaja, A.D, Debaille, V, Des Marais, D.J, Dixon, M, Ehlmann, B.L, Farmer, J.D, Fernandez-Remolar, D.C, Filiberto, J, Fogarty, J, Glavin, D.P, Goreva, Y.S, Hallis, L.J, Harrington, A.D, Hausrath, E.M, Herd, C.D.K, Horgan, B, Humayun, M, Kleine, T, Kleinhenz, J, Mackelprang, R, Mangold, N, Mayhew, L.E, McCoy, J.T, McCubbin, F.M, McLennan, S.M, Moser, D.E, Moynier, F, Mustard, J.F, Niles, P.B, Ori, G.G, Raulin, F, Rettberg, P, Rucker, M.A, Schmitz, N, Schwenzer, S.P, Sephton, M.A, Shaheen, R, Sharp, Z.D, Shuster, D.L, Siljeström, S, Smith, C.L, Spry, J.A, Steele, A, Swindle, T.D, Kate, I.L, Tosca, N.J, Usui, T, Van Kranendonk, M.J, Wadhwa, M, Weiss, B.P, Werner, S.C, Westall, F, Wheeler, R.M, Zipfel, J, and Zorzano, M.P

Published
2018

12. Seeking Signs of Life on Mars: the Importance of Sedimentary Suites as Part of a Mars Sample Return Campaign

Author

Mangold, N, McLennan, S. M, Czaja, A. D, Ori, G. G, Tosca, N. J, Altieri, F, Amelin, Y, Ammannito, E, Anand, M, Beaty, D. W, Benning, L. G, Bishop, J. L, Borg, L. E, Boucher, D, Brucato, J. R, Busemann, H, Campbell, K. A, Carrier, B. L, Debaille, V, Des Marais, D. J, Dixon, M, Ehlmann, B. L, Farmer, J. D, Fernandez-Remolar, D. C, Fogarty, J, Glavin, D. P, Goreva, Y. S, Grady, M. M, Hallis, L. J, Harrington, A. D, Hausrath, E. M, Herd, C. D. K, Horgan, B, Humayun, M, Kleine, T, Kleinhenz, J, Mackelprang, R, Mayhew, L. E, McCubbin, F. M, McCoy, J. T, McSween, H. Y, Moser, D. E, Moynier, F, Mustard, J. F, Niles, P. B, Raulin, F, Rettberg, P, Rucker, M. A, Schmitz, N, Sefton-Nash, E, Sephton, M. A, Shaheen, R, Shuster, D. L, Siljeström, S, Smith, C. L, Spry, J. A, Steele, A, Swindle, T. D, ten Kate, I. L, Usui, T, Van Kranendonk, M. J, Wadhwa, M, Weiss, B. P, Werner, S. C, Westall, F, Wheeler, R. M, Zipfel, J, and Zorzano, M. P

Subjects
Space Sciences (General)
Abstract

Seeking the signs of life on Mars is often considered the "first among equal" objectives for any potential Mars Sample Return (MSR) campaign. Among the geological settings considered to have the greatest potential for recording evidence of ancient life or its pre-biotic chemistry on Mars are lacustrine (and marine, if ever present) sedimentary depositional environments. This potential, and the possibility of returning samples that could meaningfully address this objective, have been greatly enhanced by investigations of an ancient redox stratified lake system in Gale crater by the Curiosity rover.

Published
2018

13. Seeking Signs of Life on Mars: A Strategy for Selecting and Analyzing Returned Samples from Hydrothermal Deposits

Author

Campbell, K. A, Farmer, J. D, Van Kranendonk, M. J, Fernandez-Remolar, D. C, Czaja, A. D, Altieri, F, Amelin, Y, Ammannito, E, Anand, M, Beaty, D. W, Benning, L. G, Bishop, J. L, Borg, L. E, Boucher, D, Brucato, J. R, Busemann, J. R, Carrier, B. L, Debaille, V, Des Marais, D. J, Dixon, M, Ehlmann, B. L, Fogarty, James T, Glavin, D. P, Goreva, Y. S, Grady, M. M, Hallis, L. J, Harrington, A. D, Hausrath, E. M, Herd, C. D. K, Horgan, B, Humayun, M, Kleine, T, Kleinhenz, J, Mangold, N, Mackelprang, R, Mayhew, L. E, McCubbin, F. M, Mccoy, Teresa R, McLennan, S. M, McSween, H. Y, Moser, D. E, Moynier, F, Mustard, J. F, Niles, P. B, Ori, G. G, Raulin, F, Rettberg, P, Rucker, Michelle A, Schmitz, N, Sefton-Nash, E, Sephton, M. A, Shaheen, R, Shuster, D. L, Siljestrom, S, Smith, C. L, Spry, J. A, Steele, A, Swindle, T. D, ten Kate, I. L, Tosca, N. J, Usui, T, Wadhwa, M, Weiss, B. P, Werner, S. C, Westall, F, Wheeler, R. M, Zipfel, J, and Zorzano, M. P

Subjects
Space Sciences (General)
Abstract

Highly promising locales for biosignature prospecting on Mars are ancient hydrothermal deposits, formed by the interaction of surface water with heat from volcanism or impacts. On Earth, they occur throughout the geological record (to at least approx. 3.5 Ga), preserving robust mineralogical, textural and compositional evidence of thermophilic microbial activity. Hydrothermal systems were likely present early in Mars' history, including at two of the three finalist candidate landing sites for M2020, Columbia Hills and NE Syrtis Major. Hydrothermal environments on Earth's surface are varied, constituting subaerial hot spring aprons, mounds and fumaroles; shallow to deep-sea hydrothermal vents (black and white smokers); and vent mounds and hot-spring discharges in lacustrine and fluvial settings. Biological information can be preserved by rapid, spring-sourced mineral precipitation, but also could be altered or destroyed by postdepositional events. Thus, field observations need to be followed by detailed laboratory analysis to verify potential biosignatures. See Attachment

Published
2018

14. Autophagy is differentially regulated in leukocyte and nonleukocyte foam cells during atherosclerosis

Author

Robichaud, S., primary, Rasheed, A., additional, Pietangelo, A., additional, Kim, A. Doyoung, additional, Boucher, D., additional, Emerton, C., additional, Vijithakumar, V., additional, Gharibeh, L., additional, Fairman, G., additional, Mak, E., additional, Nguyen, M.-A., additional, Geoffrion, M., additional, Wirka, R., additional, Rayner, K., additional, and Ouimet, M., additional

Published
2022
Full Text
View/download PDF

16. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

Author

Lajaunie, Rébecca, Cuzin, Lise, Palich, Romain, Makinson, Alain, Bani-Sadr, Firouzé, Duvivier, Claudine, Arvieux, Cedric, Rey, David, Poizot-Martin, Isabelle, Delpierre, Cyril, Delobel, Pierre, Martin-Blondel, Guillaume, Chirouze, C., Drobacheff-Thiébaut, C., Foltzer, A., Bouiller, K., Hustache- Mathieu, L., Lepiller, Q., Bozon, F., Babre, O, Brunel, As., Muret, P., Chevalier, E., Jacomet, C., Laurichesse, H., Lesens, O., Vidal, M., Mrozek, N., Aumeran, C., Baud, O., Corbin, V., Goncalvez, E., Mirand, A, Brebion, A, Henquell, C, Lamaury, I., Fabre, I., Curlier, E., Ouissa, R., Herrmann-Storck, C., Tressieres, B., Receveur, Mc., Boulard, F., Daniel, C., Clavel, C., Roger, Pm., Markowicz, S., Chellum Rungen, N., Merrien, D., Perré, P., Guimard, T., Bollangier, O., Leautez, S., Morrier, M., Laine, L., Boucher, D., Point, P., Cotte, L., Ader, F., Becker, A., Boibieux, A., Brochier, C., Brunel-Dalmas, F., Cannesson, O., Chiarello, P., Chidiac, C., Degroodt, S., Ferry, T., Godinot, M., Livrozet, J.M., Makhloufi, D., Miailhes, P., Perpoint, T., Perry, M., Pouderoux, C., Roux, S., Triffault-Fillit, C., Valour, F., Charre, C., Icard, V., Tardy, J.C., Trabaud, M.A., Ravaux, I., Ménard, A., Belkhir, Ay., Colson, P., Dhiver, C., Madrid, A., Martin-Degioanni, M., Meddeb, L., Mokhtari, M., Motte, A., Raoux, A., Toméi, C., Tissot-Dupont, H., Poizot-Martin, I., Brégigeon, S., Zaegel-Faucher, O., Obry-Roguet, V., Laroche, H, Orticoni, M., Soavi, M.J., Ressiot, E., Ducassou, M.J., Jaquet, I., Galie, S., Colson, H., Ritleng, A.S., Ivanova, A., Debreux, C., Lions, C., Rojas-Rojas, T, Cabié, A., Abel, S., Bavay, J., Bigeard, B., Cabras, O., Cuzin, L., Dupin de Majoubert, R., Fagour, L., Guitteaud, K., Marquise, A., Najioullah, F., Pierre-François, S., Pasquier, J., Richard, P., Rome, K., Turmel, Jm, Varache, C., Atoui, N., Bistoquet, M., Delaporte, E, Le Moing, V., Makinson, A., Meftah, N., Merle de Boever, C., Montes, B., Montoya Ferrer, A., Tuaillon, E., Reynes, J., Lefèvre, B., Jeanmaire, E., Hénard, S., Frentiu, E., Charmillon, A., Legoff, A., Tissot, N., André, M., Boyer, L., Bouillon, Mp., Delestan, M., Goehringer, F., Bevilacqua, S., Rabaud, C., May, T., Raffi, F., Allavena, C., Aubry, O., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Brunet-Cartier, C., Deschanvres, C., Gaborit, B.J., Grégoire, A., Grégoire, M., Grossi, O., Guéry, R., Jovelin, T., Lefebvre, M., Le Turnier, P., Lecomte, R., Morineau, P., Reliquet, V., Sécher, S., Cavellec, M., Paredes, E., Soria, A., Ferré, V., André-Garnier, E., Rodallec, A., Pugliese, P., Breaud, S., Ceppi, C., Chirio, D., Cua, E., Dellamonica, P., Demonchy, E., de Monte, A., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Michelangeli, C., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Carles, M., Klotz, C., Maka, A., Pradier, C., Prouvost-Keller, B., Risso, K., Rio, V., Rosenthal, E., Touitou, I., Wehrlen-Pugliese, S., Zouzou, G., Hocqueloux, L., Prazuck, T., Gubavu, C., Sève, A., Giaché, S., Rzepecki, V., Colin, M., Boulard, C., Thomas, G., Cheret, A., Goujard, C., Quertainmont, Y., Teicher, E., Lerolle, N., Jaureguiberry, S., Colarino, R., Deradji, O., Castro, A., Barrail-Tran, A., Yazdanpanah, Y., Landman, R., Joly, V., Ghosn, J., Rioux, C., Lariven, S., Gervais, A., Lescure, Fx., Matheron, S., Louni, F., Julia, Z., Le Gac, S., Charpentier, C., Descamps, D., Peytavin, G., Duvivier, C., Aguilar, C., Alby-Laurent, F., Amazzough, K., Benabdelmoumen, G., Bossi, P., Cessot, G., Charlier, C., Consigny, P.H., Jidar, K., Lafont, E., Lanternier, F., Leporrier, J., Lortholary, O., Louisin, C., Lourenco, J., Parize, P., Pilmis, B., Rouzaud, C., Touam, F., Valantin, Ma., Tubiana, R., Agher, R., Seang, Sophie, Schneider, L., Palich, R., Blanc, C., Katlama, C., Bani-Sadr, F., Berger, Jl., N’guyen, Y., Lambert, D., Kmiec, I., Hentzien, M., Brunet, A., Romaru, J., Marty, H., Brodard, V., Arvieux, C., Tattevin, P., Revest, M., Souala, F., Baldeyrou, M., Patrat-Delon, S., Chapplain, J.M., Benezit, F., Dupont, M., Poinot, M., Maillard, A., Pronier, C., Lemaitre, F., Morlat, C., Poisson-Vannier, M., Sinteff, Jp., Gagneux-Brunon, A., Botelho-Nevers, E., Frésard, A., Ronat, V., Lucht, F., Rey, D., Fischer, P., Partisani, M., Cheneau, C., Priester, M., Batard, Ml., Mélounou, C, Bernard-Henry, C., de Mautort, E., Fafi-Kremer, S., Delobel, P., Alvarez, M., Biezunski, N., Debard, A., Delpierre, C., Gaube, G., Lansalot, P., Lelièvre, L., Marcel, M., Martin-Blondel, G., Piffaut, M., Porte, L., Saune, K., Robineau, O., Ajana, F., Aïssi, E., Alcaraz, I., Alidjinou, E., Baclet, V., Bocket, L., Boucher, A., Digumber, M., Huleux, T., Lafon-Desmurs, B., Meybeck, A., Pradier, M., Tetart, M., Thill, P., Viget, N., Valette, M., Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU de la Martinique [Fort de France], Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Universitaire de Reims (CHU Reims), Service des Maladies infectieuses et tropicales [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre Médical de l'Institut Pasteur (CMIP), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), CHU Pontchaillou [Rennes], CHU Strasbourg, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Toulouse III Paul Sabatier - Faculté de médecine Purpan (UTPS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), And The Dat’AIDS study group: C Chirouze, C Drobacheff-Thiébaut, A Foltzer, K Bouiller, L Hustache-Mathieu, Q Lepiller, F Bozon, O Babre, A S Brunel, P Muret, E Chevalier, C Jacomet, H Laurichesse, O Lesens, M Vidal, N Mrozek, C Aumeran, O Baud, V Corbin, E Goncalvez, A Mirand, A Brebion, C Henquell, I Lamaury, I Fabre, E Curlier, R Ouissa, C Herrmann-Storck, B Tressieres, M C Receveur, F Boulard, C Daniel, C Clavel, P M Roger, S Markowicz, N Chellum Rungen, D Merrien, P Perré, T Guimard, O Bollangier, S Leautez, M Morrier, L Laine, D Boucher, P Point, L Cotte, F Ader, A Becker, A Boibieux, C Brochier, F Brunel-Dalmas, O Cannesson, P Chiarello, C Chidiac, S Degroodt, T Ferry, M Godinot, J M Livrozet, D Makhloufi, P Miailhes, T Perpoint, M Perry, C Pouderoux, S Roux, C Triffault-Fillit, F Valour, C Charre, V Icard, J C Tardy, M A Trabaud, I Ravaux, A Ménard, A Y Belkhir, P Colson, C Dhiver, A Madrid, M Martin-Degioanni, L Meddeb, M Mokhtari, A Motte, A Raoux, C Toméi, H Tissot-Dupont, I Poizot-Martin, S Brégigeon, O Zaegel-Faucher, V Obry-Roguet, H Laroche, M Orticoni, M J Soavi, E Ressiot, M J Ducassou, I Jaquet, S Galie, H Colson, A S Ritleng, A Ivanova, C Debreux, C Lions, T Rojas-Rojas, A Cabié, S Abel, J Bavay, B Bigeard, O Cabras, L Cuzin, R Dupin de Majoubert, L Fagour, K Guitteaud, A Marquise, F Najioullah, S Pierre-François, J Pasquier, P Richard, K Rome, J M Turmel, C Varache, N Atoui, M Bistoquet, E Delaporte, V Le Moing, A Makinson, N Meftah, C Merle de Boever, B Montes, A Montoya Ferrer, E Tuaillon, J Reynes, B Lefèvre, E Jeanmaire, S Hénard, E Frentiu, A Charmillon, A Legoff, N Tissot, M André, L Boyer, M P Bouillon, M Delestan, F Goehringer, S Bevilacqua, C Rabaud, T May, F Raffi, C Allavena, O Aubry, E Billaud, C Biron, B Bonnet, S Bouchez, D Boutoille, C Brunet-Cartier, C Deschanvres, B J Gaborit, A Grégoire, M Grégoire, O Grossi, R Guéry, T Jovelin, M Lefebvre, P Le Turnier, R Lecomte, P Morineau, V Reliquet, S Sécher, M Cavellec, E Paredes, A Soria, V Ferré, E André-Garnier, A Rodallec, P Pugliese, S Breaud, C Ceppi, D Chirio, E Cua, P Dellamonica, E Demonchy, A De Monte, J Durant, C Etienne, S Ferrando, R Garraffo, C Michelangeli, V Mondain, A Naqvi, N Oran, I Perbost, M Carles, C Klotz, A Maka, C Pradier, B Prouvost-Keller, K Risso, V Rio, E Rosenthal, I Touitou, S Wehrlen-Pugliese, G Zouzou, L Hocqueloux, T Prazuck, C Gubavu, A Sève, S Giaché, V Rzepecki, M Colin, C Boulard, G Thomas, A Cheret, C Goujard, Y Quertainmont, E Teicher, N Lerolle, S Jaureguiberry, R Colarino, O Deradji, A Castro, A Barrail-Tran, Y Yazdanpanah, R Landman, V Joly, J Ghosn, C Rioux, S Lariven, A Gervais, F X Lescure, S Matheron, F Louni, Z Julia, S Le Gac, C Charpentier, D Descamps, G Peytavin, C Duvivier, C Aguilar, F Alby-Laurent, K Amazzough, G Benabdelmoumen, P Bossi, G Cessot, C Charlier, P H Consigny, K Jidar, E Lafont, F Lanternier, J Leporrier, O Lortholary, C Louisin, J Lourenco, P Parize, B Pilmis, C Rouzaud, F Touam, M A Valantin, R Tubiana, R Agher, S Seang, L Schneider, R Palich, C Blanc, C Katlama, F Bani-Sadr, J L Berger, Y N'Guyen, D Lambert, I Kmiec, M Hentzien, A Brunet, J Romaru, H Marty, V Brodard, C Arvieux, P Tattevin, M Revest, F Souala, M Baldeyrou, S Patrat-Delon, J M Chapplain, F Benezit, M Dupont, M Poinot, A Maillard, C Pronier, F Lemaitre, C Morlat, M Poisson-Vannier, T Jovelin, J P Sinteff, A Gagneux-Brunon, E Botelho-Nevers, A Frésard, V Ronat, F Lucht, D Rey, P Fischer, M Partisani, C Cheneau, M Priester, M L Batard, C Mélounou, C Bernard-Henry, E de Mautort, S Fafi-Kremer, P Delobel, M Alvarez, N Biezunski, A Debard, C Delpierre, G Gaube, P Lansalot, L Lelièvre, M Marcel, G Martin-Blondel, M Piffaut, L Porte, K Saune, O Robineau, F Ajana, E Aïssi, I Alcaraz, E Alidjinou, V Baclet, L Bocket, A Boucher, M Digumber, T Huleux, B Lafon-Desmurs, A Meybeck, M Pradier, M Tetart, P Thill, N Viget, M Valette, Malbec, Odile, Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Toulouse (UT)-Université de Toulouse (UT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Maladies Infectieuses et Tropicales [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Rennes (CHU Rennes), Laboratoire de Physique des Lasers (LPL), Université Paris 13 (UP13)-Centre National de la Recherche Scientifique (CNRS)-Université Sorbonne Paris Nord, Service d'Immuno-hématologie clinique [Hôpital Sainte Marguerite - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Institut des sciences de la santé publique [Marseille] (ISSPAM), European Infective Endocarditis Registry (Euro-Endo), EMERGEN consortium, Stratégies thérapeutiques contre l'infection VIH et les maladies virales associées [iPLesp] (THERAVIR), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Laboratoire Microorganismes : Génome et Environnement (LMGE), and Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)

Subjects
medicine.medical_specialty, MESH: CD4 Lymphocyte Count, [SDV]Life Sciences [q-bio], antiretroviral therapy, Human immunodeficiency virus (HIV), protease inhibitors, HIV Infections, medicine.disease_cause, MESH: HIV-1, Acquired immunodeficiency syndrome (AIDS), MESH: Neoplasm Recurrence, Local / complications, Internal medicine, medicine, Humans, HHV8, MESH: HIV Infections* / complications, MESH: Protease Inhibitors / adverse effects, Pharmacology (medical), Protease inhibitor (pharmacology), Sarcoma, Kaposi, Retrospective Studies, MESH: Humans, business.industry, Health Policy, Kaposi sarcoma, MESH: Retrospective Studies, Viral Load, MESH: HIV Infections* / drug therapy, medicine.disease, Antiretroviral therapy, switch, CD4 Lymphocyte Count, AIDS, [SDV] Life Sciences [q-bio], Regimen, Infectious Diseases, Increased risk, MESH: Sarcoma, Kaposi* / drug therapy, HIV-1, Sarcoma, Neoplasm Recurrence, Local, business, MESH: Viral Load, Viral load
Abstract

International audience; Objectives: Our aim was to assess if switching from a protease inhibitors (PI)-based regimen to a PI-free one is associated with an increased risk of Kaposi Sarcoma (KS) relapse among patients living with HIV (PLHIV) with history of KS and controlled HIV replication.Methods: In a retrospective analysis of the prospectively collected Dat'AIDS database we selected patients who both had a past KS history and a HIV-1 viral load below 200 copies/mL while being PI-treated. We searched for KS relapses while persistent virological success was maintained for at least 6 months, whether patients kept taking the PI, or switched to PI-free regimen.Results: Among the 216 patients with past KS event and a history of HIV-1 infection efficiently treated by a PI-based regimen, 148 patients (68.5%) later switched to a PI-sparing regimen. Their baseline characteristics were not different from non-switching patients. We described 7 cases of relapse (3.2% of the 216 patients). Five cases of relapse occurred in switching patients (3.4%). The remaining two relapses occurred in PI-treated patients (2.9%). At KS relapse, CD4 cell count was 459 cells/μL (range 225-560) for switching patients, compared with 362 and 136 cells/μL for the other two patients.Conclusions: In this large cohort of PLHIV with a history of KS and ART-controlled HIV replication, KS relapses were described in 3.2% of the patients, and were not more frequent when a PI-containing ART regimen has been switched to a PI-free regimen. Our results do not support a specific effect of PI on KS.

Published
2022
Full Text
View/download PDF

17. Vulnerability of timber supply to projected changes in fire regime in Canada's managed forests

Author

Gauthier, S., Bernier, P.Y., Boulanger, Y., Guo, J., Guindon, L., Beaudoin, A., and Boucher, D.

Subjects
Forest fires -- Environmental aspects -- Economic aspects, Forest productivity -- Economic aspects, Timber -- Environmental aspects -- Economic aspects, Earth sciences
Abstract

The frequency of forest fires is predicted to increase in Canada, which may affect the availability of timber for industrial purposes. We therefore carried out an evaluation of the timber supply vulnerability to current and future fire risk through simplified calculations involving historical forest growth and harvest rates and current and projected forest burn rates. Calculations were performed at the level of forest management areas (FMAs) across the boreal and montane ecozones of Canada. For some FMAs, the vulnerability of timber supply to fire was estimated to be high to extreme by the middle of the century. For those FMAs, the increases in tree growth necessary to negate these risks were generally unrealistic. A modest simulated decrease in tree growth over time, however, was sufficient to raise the vulnerability of many other FMAs from low to moderate. Known biases in the analysis suggest that our assessment might underestimate the level of vulnerability in all FMAs. Other natural disturbances are not included in the analysis but their impact on timber supply may be additive to that of fire. Some adaptation measures to face these increasing risks are discussed. Key words: boreal forest, productive capacity, fire risk, climate change, vulnerability. Les predictions courantes suggerent une augmentation de la frequence des feux au Canada, ce qui pourrait affecter la disponibilite en bois pour des fins industrielles. Nous avons donc evalue la vulnerabilite de l'approvisionnement en bois au risque de feux actuel et futur grace a des calculs simplifies impliquant les taux de recolte et la croissance historiques de la foret, ainsi que les regimes de feux actuels et projetes. Les calculs ont ete effectues au niveau des unites d'amenagement forestier (UAF) compris dans les ecozones boreales et montagnardes du Canada. Pour certaines UAF, l'analyse suggere une vulnerabilite elevee a extreme de l'approvisionnement en bois au feu d'ici le milieu du siecle. Pour ces UAF, les augmentations de croissance des arbres necessaires a attenuer ces risques sont generalement irrealistes. Une diminution modeste de la croissance de l'arbre au fil du tempsserait cependant suffisante pour augmenter de faible a moderee la vulnerabilite de nombreuses autres UAF. Des biais connus dans l'analyse suggerent que notre evaluation pourrait sous-estimer le niveau de vulnerabilite dans toutes les UAF. Les autres perturbations naturelles ne sont pas incluses dans l'analyse, mais leurs impacts sur l'approvisionnement en bois pourraient etre additifs a celui du feu. Certaines mesures d'adaptation pour faire face a ces risques croissants sont presentees. Mots-cles: foret boreale, capacite productive, risque de feu, changement climatique, vulnerabilite., Introduction Forest fire is a major disturbance that can compete with harvesting or other forest uses in many parts of the world, notably in boreal and Mediterranean biomes (Marlon et [...]

Published
2015
Full Text
View/download PDF

20. A note on the duality of skew module codes

Author

Boucher, D, Boucher, Delphine, Institut de Recherche Mathématique de Rennes (IRMAR), Université de Rennes (UR)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École normale supérieure - Rennes (ENS Rennes)-Université de Rennes 2 (UR2)-Centre National de la Recherche Scientifique (CNRS)-Institut Agro Rennes Angers, and Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)

Subjects
[INFO.INFO-SC]Computer Science [cs]/Symbolic Computation [cs.SC], [MATH.MATH-IT] Mathematics [math]/Information Theory [math.IT], [INFO.INFO-SC] Computer Science [cs]/Symbolic Computation [cs.SC], [MATH.MATH-IT]Mathematics [math]/Information Theory [math.IT]
Abstract

International audience; We introduce a new notion of duality inspired from the paper On the duality and the direction of polycyclic codes by Adel Alahmadi, Steven Dougherty, André Leroy and Patrick Solé. We get that the dual of a central skew module code is a central skew module code.

Published
2022

22. Role and Requirements for Plasma Measurements on ITER

Author

ITER Joint Central Team and Home Teams, Mukhovatov, V. S., Bartiromo, R., Boucher, D., Costley, A. E., de Kock, L., Ebisawa, K., Edmonds, P., Gribov, Yu., Janeschitz, G., Johnson, L. C., Kasai, S., Marmar, E., Nagashima, A., Petrov, M., Post, D. E., Stott, P. E., Strelkov, V. S., Vayakis, G., Walker, C. I., Wesley, J., Yamamoto, S., Young, K. M., Zaveriaev, V. S., Stott, Peter E., editor, Gorini, Giuseppe, editor, Prandoni, Paolo, editor, and Sindoni, Elio, editor

Published
1998
Full Text
View/download PDF

27. Poster Session

Author

Sandlund, L., Fahlander, M., Amadei, M. M., Gonnard, P., Eyraud, L., Boucher, D., Reyne, G., Letiche, M., Grosso, G., Delany, J., Jonės, D. F., Janacek, T. K., Baker, S. R., McLean, K. A., Scandrett, C. L., Canright, D. R., Kuntsal, E., Ellis, J., Fanning, B., McMahon, G. W., Tito, F. A., Brigham, G., McTaggart, B., Sernit, E., Mazoyer, T., Garcin, J., Hamonic, Bernard F., editor, Decarpigny, Jean-Nöel, editor, and Wilson, Oscar B., editor

Published
1991
Full Text
View/download PDF

35. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018

Author

Pradat, Pierre, Chirouze, C, Drobacheff-Thiébaut, C, Foltzer, A, Bouiller, K, Hustache-Mathieu, L, Lepiller, Q, Bozon, F, Babre, O, Brunel, A, Muret, P, Chevalier, E, Jacomet, C, Laurichesse, H, LESENS, O, Vidal, M, Mrozek, N, Aumeran, C, Baud, O, Corbin, V, Goncalvez, E, Mirand, A, brebion, A, Henquell, C, Lamaury, I, Fabre, I, Curlier, E, Ouissa, R, Herrmann-Storck, C, Tressieres, B, Receveur, M, Boulard, F, Daniel, C, CLAVEL, C, Roger, P, Markowicz, S, Chellum Rungen, N, Merrien, D, Perré, P, Guimard, T, Bollangier, O, Leautez, S, Morrier, M, Laine, L, Boucher, D, Point, P, Cotte, Laurent, Ader, F, Becker, A, Boibieux, A, Brochier, C, Brunel-Dalmas, F, Cannesson, O, Chiarello, P, Chidiac, C, Degroodt, S, FERRY, T, Godinot, M, Livrozet, J, Makhloufi, D, Miailhes, P, Perpoint, T, Perry, M, Pouderoux, C, Roux, Stéphane, Triffault-Fillit, C, Valour, F, Charre, C, Icard, V, Tardy, J, Trabaud, M, Ravaux, I, Ménard, A, Belkhir, A, Colson, P, Dhiver, C, Madrid, A, Martin-Degioanni, M, Meddeb, L, Mokhtari, M, Motte, A, Raoux, A, Toméi, C, Tissot-Dupont, H, Poizot-Martin, Isabelle, Brégigeon, S, Zaegel-Faucher, O, Obry-Roguet, V, Laroche, H, Orticoni, M, Soavi, M, Ressiot, E, Ducassou, M, Jaquet, I, Galie, S, Colson, H, Ritleng, A, Ivanova, A, Debreux, C, Lions, C, Rojas-Rojas, T, Cabié, André, Abel, S, Bavay, J, Bigeard, B, Cabras, O, Cuzin, L, Dupin de Majoubert, R, Fagour, L, Guitteaud, K, Marquise, A, Najioullah, F, Pierre-François, S, Pasquier, J, Richard, P, Rome, K, Turmel, J, Varache, C, Atoui, N, Bistoquet, M, Delaporte, E, Le Moing, V, Makinson, A, Meftah, N, Merle de Boever, C, Montes, B, Montoya Ferrer, A, Tuaillon, E, Reynes, J, Lefèvre, B, Jeanmaire, E, Hénard, S, Frentiu, E, Charmillon, A, Legoff, A, Tissot, N, André, M, Boyer, L, Bouillon, M, Delestan, M, Goehringer, F, Bevilacqua, S, Rabaud, C, May, T, Raffi, F, Allavena, C, Aubry, O, Billaud, E, Biron, C, Bonnet, B, Bouchez, S, Boutoille, D, Brunet-Cartier, C, Deschanvres, C, Gaborit, B, Grégoire, A, Grégoire, M, Grossi, O, Guéry, R, Lefebvre, Maeva, Le Turnier, P, Lecomte, R, Morineau, P, Reliquet, V, Sécher, S, Cavellec, M, Paredes, E, Soria, A, Ferré, V, André-Garnier, E, Rodallec, A, Pugliese, Pascal, Breaud, S, Ceppi, C, Chirio, D, Cua, E, Dellamonica, P, Demonchy, E, De Monte, A, Durant, J, Etienne, C, Ferrando, S, Garraffo, R, Michelangeli, C, Mondain, V, Naqvi, A, Oran, N, Perbost, I, Carles, M, Klotz, C, Maka, A, Pradier, C, Prouvost-Keller, B, Risso, K, Rio, V, Rosenthal, E, Touitou, I, Wehrlen-Pugliese, S, Zouzou, G, Hocqueloux, Laurent, Prazuck, T, Gubavu, C, Sève, A, Giaché, S, Rzepecki, V, Colin, M, Boulard, C, Thomas, G, Cheret, A, Goujard, C, Quertainmont, Y, Teicher, E, Lerolle, N, Jaureguiberry, S, Colarino, R, Deradji, O, Castro, A, Barrail-Tran, A, Yazdanpanah, Y, Landman, R, Joly, V, Ghosn, J, Rioux, C, Lariven, S, gervais, a, Lescure, F, Matheron, S, Louni, F, Julia, Z, Le Gac, S, Charpentier, c, Descamps, D, Peytavin, G, Duvivier, C, Aguilar, C, Alby-Laurent, F, Amazzough, K, Benabdelmoumen, G, Bossi, P, Cessot, G, Charlier, C, Consigny, P, Jidar, K, Lafont, E, Lanternier, F, Leporrier, J, Lortholary, O, Louisin, C, Lourenco, J, Parize, P, Pilmis, B, Rouzaud, C, Touam, F, Valantin, M, Tubiana, R, Agher, R, Seang, S, Schneider, L, PaLich, R, Blanc, C, Katlama, C, Bani-Sadr, Firouze, Berger, J, N’Guyen, Y, Lambert, D, Kmiec, I, Hentzien, M, Brunet, A, Romaru, J, Marty, H, Brodard, V, Arvieux, C, Tattevin, P, Revest, M, Souala, F, Baldeyrou, M, Patrat-Delon, S, Chapplain, J, Benezit, F, Dupont, M, Poinot, M, MAILLARD, A, Pronier, C, Lemaitre, F, Morlat, C, Poisson-Vannier, M, Jovelin, T, Sinteff, J, Gagneux-Brunon, A, Botelho-Nevers, E, Frésard, A, Ronat, V, Lucht, F, Rey, David, Fischer, P, Partisani, M, Cheneau, C, Priester, M, Mélounou, C, Bernard-Henry, C, de Mautort, E, Fafi-Kremer, S, Delobel, P, Alvarez, M, Biezunski, N, Debard, A, Delpierre, C, Gaube, G, Lansalot, P, Lelièvre, L, Marcel, M, Martin-Blondel, G, Piffaut, M, Porte, L, Saune, K, Robineau, O, Ajana, F, Aïssi, E, Alcaraz, I, Alidjinou, E, Baclet, V, Bocket, L, Boucher, A, Digumber, M, Huleux, Thomas, Lafon-Desmurs, B, Meybeck, A, Pradier, M, Tetart, M, Thill, P, Viget, N, Valette, M, Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), Université des Antilles (UA)-Etablissement français du don du sang [Montpellier]-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Centre Hospitalier Régional d'Orléans (CHRO), Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital universitaire Robert Debré [Reims], Centre Hospitalier Gustave Dron [Tourcoing], Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Aix Marseille Université (AMU), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Nice (CHU Nice), Hôpital l'Archet, Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Université des Antilles (UA), Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane), Université des Antilles et de la Guyane (UAG)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], Dat’AIDS Study Group Besançon: C. Chirouze, C. Drobacheff-Thiébaut, A. Foltzer, K. Bouiller, L. Hustache- Mathieu, Q. Lepiller, F. Bozon, O. Babre, AS. Brunel, P. Muret, E. Chevalier. Clermont-Ferrand: C. Jacomet, H. Laurichesse, O. Lesens, M. Vidal, N. Mrozek, C. Aumeran, O. Baud, V. Corbin, E. Goncalvez, A Mirand, A brebion, C Henquell. Guadeloupe: I. Lamaury, I. Fabre, E. Curlier, R. Ouissa, C. Herrmann-Storck, B. Tressieres, MC. Receveur, F. Boulard, C. Daniel, C. Clavel, PM. Roger, S. Markowicz, N. Chellum Rungen. La Roche sur Yon: D. Merrien, P. Perré, T. Guimard, O. Bollangier, S. Leautez, M. Morrier, L. Laine, D. Boucher, P. Point. Lyon: L. Cotte, F. Ader, A. Becker, A. Boibieux, C. Brochier F, Brunel-Dalmas, O. Cannesson, P. Chiarello, C. Chidiac, S. Degroodt, T. Ferry, M. Godinot, J.M. Livrozet, D. Makhloufi, P. Miailhes, T. Perpoint, M. Perry, C. Pouderoux, S. Roux, C. Triffault-Fillit, F. Valour, C. Charre, V. Icard, J.C. Tardy, M.A. Trabaud. Marseille IHU Méditerrannée: I. Ravaux, A. Ménard, AY. Belkhir, P. Colson, C. Dhiver, A. Madrid, M. Martin-Degioanni, L. Meddeb, M. Mokhtari, A. Motte, A. Raoux, C. Toméi, H. Tissot-Dupont. Marseille Ste Marguerite: I. Poizot-Martin, S. Brégigeon, O. Zaegel-Faucher, V. Obry-Roguet, H Laroche, M. Orticoni, M.J. Soavi, E. Ressiot, M.J. Ducassou, I. Jaquet, S. Galie, H. Colson, A.S. Ritleng, A. Ivanova, C. Debreux, C. Lions, T Rojas-Rojas. Martinique: A. Cabié, S. Abel, J. Bavay, B. Bigeard, O. Cabras, L. Cuzin, R. Dupin de Majoubert, L. Fagour, K. Guitteaud, A. Marquise, F. Najioullah, S. Pierre-François, J. Pasquier, P. Richard, K. Rome, JM Turmel, C. Varache. Montpellier: N. Atoui, M. Bistoquet, E Delaporte, V. Le Moing, A. Makinson, N. Meftah, C. Merle de Boever, B. Montes, A. Montoya Ferrer, E. Tuaillon, J. Reynes. Nancy: B. Lefèvre, E. Jeanmaire, S. Hénard, E. Frentiu, A. Charmillon, A. Legoff, N. Tissot, M. André, L. Boyer, MP. Bouillon, M. Delestan, F. Goehringer, S. Bevilacqua, C. Rabaud, T. May. Nantes: F. Raffi, C. Allavena, O. Aubry, E. Billaud, C. Biron, B. Bonnet, S. Bouchez, D. Boutoille, C. Brunet-Cartier, C. Deschanvres, B.J. Gaborit, A. Grégoire, M. Grégoire, O. Grossi, R. Guéry, T. Jovelin, M. Lefebvre, P. Le Turnier, R. Lecomte, P. Morineau, V. Reliquet, S. Sécher, M. Cavellec, E. Paredes, A. Soria, V. Ferré, E. André-Garnier, A. Rodallec. Nice: P. Pugliese, S. Breaud, C. Ceppi, D. Chirio, E. Cua, P. Dellamonica, E. Demonchy, A. De Monte, J. Durant, C. Etienne, S. Ferrando, R. Garraffo, C. Michelangeli, V. Mondain, A. Naqvi, N. Oran, I. Perbost, M. Carles, C. Klotz, A. Maka, C. Pradier, B. Prouvost- Keller, K. Risso, V. Rio, E. Rosenthal, I. Touitou, S. Wehrlen-Pugliese, G. Zouzou. Orléans: L. Hocqueloux, T. Prazuck, C. Gubavu, A. Sève, S. Giaché, V. Rzepecki, M. Colin, C. Boulard, G. Thomas. Paris APHP Bicètre: A. Cheret, C. Goujard, Y. Quertainmont, E. Teicher, N. Lerolle, S. Jaureguiberry, R. Colarino, O. Deradji, A. Castro, A. Barrail-Tran. Paris APHP Bichat: Y. Yazdanpanah, R. Landman, V. Joly, J. Ghosn, C. Rioux, S. Lariven, A. Gervais, FX. Lescure, S. Matheron, F. Louni, Z. Julia, S. Le GAC, C. Charpentier, D. Descamps, G. Peytavin. Paris APHP Necker Pasteur: C. Duvivier, C. Aguilar, F. Alby-Laurent, K. Amazzough, G. Benabdelmoumen, P. Bossi, G. Cessot, C. Charlier, P.H. Consigny, K. Jidar, E. Lafont, F. Lanternier, J. Leporrier, O. Lortholary, C. Louisin, J. Lourenco, P. Parize, B. Pilmis, C. Rouzaud, F. Touam. Paris APHP Pitié Salpetrière: MA. Valantin, R. Tubiana, R. Agher, S. Seang, L. Schneider, R. PaLich, C. Blanc, C. Katlama. Reims: F. Bani-Sadr, JL. Berger, Y. N’Guyen, D. Lambert, I. Kmiec, M. Hentzien, A. Brunet, J. Romaru, H. Marty, V. Brodard. Rennes: C. Arvieux, P. Tattevin, M. Revest, F. Souala, M. Baldeyrou, S. Patrat-Delon, J.M. Chapplain, F. Benezit, M. Dupont, M. Poinot, A. Maillard, C. Pronier, F. Lemaitre, C. Morlat, M. Poisson-Vannier, T. Jovelin, JP. Sinteff. St Etienne: A. Gagneux-Brunon, E. Botelho-Nevers, A. Frésard, V. Ronat, F. Lucht. Strasbourg: D. Rey, P. Fischer, M. Partisani, C. Cheneau, M. Priester, C. Mélounou, C. Bernard-Henry, E. de Mautort, S. Fafi-Kremer. Toulouse: P. Delobel, M. Alvarez, N. Biezunski, A. Debard, C. Delpierre, G. Gaube, P. Lansalot, L. Lelièvre, M. Marcel, G. Martin-Blondel, M. Piffaut, L. Porte, K. Saune. Tourcoing: O. Robineau, F. Ajana, E. Aïssi, I. Alcaraz, E. Alidjinou, V. Baclet, L. Bocket, A. Boucher, M. Digumber, T. Huleux, B. Lafon-Desmurs, A. Meybeck, M. Pradier, M. Tetart, P. Thill, N. Viget, M. Valette., CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles et de la Guyane (UAG), and Malbec, Odile

Subjects
Microbiology (medical), Male, medicine.medical_specialty, Hepatitis C virus, [SDV]Life Sciences [q-bio], Population, men having sex with men, HIV Infections, Hepacivirus, medicine.disease_cause, Antiviral Agents, Men who have sex with men, 03 medical and health sciences, Sexual and Gender Minorities, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Human Immunodeficiency virus, Homosexuality, Male, education, Retrospective Studies, Hepatitis, education.field_of_study, business.industry, Coinfection, Mortality rate, Incidence (epidemiology), microelimination, virus diseases, HIV, Hepatitis C, Chronic, medicine.disease, Hepatitis C, digestive system diseases, 3. Good health, [SDV] Life Sciences [q-bio], Infectious Diseases, Cohort, 030211 gastroenterology & hepatology, epidemiology, France, business
Abstract

Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficiency virus (HIV)-HCV–coinfected patients are deemed a priority population for HCV elimination, while a rise in recently acquired HCV infections in men who have sex with men (MSM) has been described. We describe the variations in HIV-HCV epidemiology in the French Dat’AIDS cohort. Methods This was a retrospective analysis of a prospective cohort of persons living with HIV (PLWH) from 2012 to 2018. We determined HCV prevalence, HCV incidence, proportion of viremic patients, treatment uptake, and mortality rate in the full cohort and by HIV risk factors. Results From 2012 to 2018, 50 861 PLWH with a known HCV status were followed up. During the period, HCV prevalence decreased from 15.4% to 13.5%. HCV prevalence among new HIV cases increased from 1.9% to 3.5% in MSM but remained stable in other groups. Recently acquired HCV incidence increased from 0.36/100 person-years to 1.25/100 person-years in MSM. The proportion of viremic patients decreased from 67.0% to 8.9%. MSM became the first group of viremic patients in 2018 (37.9%). Recently acquired hepatitis represented 59.2% of viremic MSM in 2018. DAA treatment uptake increased from 11.4% to 61.5%. More treatments were initiated in MSM in 2018 (41.2%) than in intravenous drug users (35.6%). In MSM, treatment at the acute phase represented 30.0% of treatments in 2018. Conclusions A major shift in HCV epidemiology was observed in PLWH in France from 2012 to 2018, leading to a unique situation in which the major group of HCV transmission in 2018 was MSM. Clinical Trials Registration. NCT02898987.

Published
2020
Full Text
View/download PDF

48. CONTRIBUTORS

Author

Spears, Ian S, Saunders, Chris, Patton, Paul, Murrey, Amber, Friedman, Steven, Elliott, Michael, Egya, Sule Emmanuel, Dladla, Ndumiso, Boisen, Camilla, Allsobrook, Christopher, Omar, Ayesha, and Boucher, David

Published
2023

49. INDEX

Author

Spears, Ian S, Saunders, Chris, Patton, Paul, Murrey, Amber, Friedman, Steven, Elliott, Michael, Egya, Sule Emmanuel, Dladla, Ndumiso, Boisen, Camilla, Allsobrook, Christopher, Omar, Ayesha, and Boucher, David

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results